Calidi Biotherapeutics, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US3207031010

USD

1.09

-0.02 (-1.8%)

Sep 23

ASE

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Actinium Pharmaceuticals, Inc.

Puma Biotechnology, Inc.

Gamida Cell Ltd.

OptiNose, Inc.

Karyopharm Therapeutics, Inc.

Mind Medicine (MindMed), Inc.

PDS Biotechnology Corp.

Calidi Biotherapeutics, Inc.

Ocean Biomedical, Inc.

Adverum Biotechnologies, Inc.

ESSA Pharma, Inc.

Why is Calidi Biotherapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Calidi Biotherapeutics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Calidi Biotherapeutics, Inc.

-95.74%

-0.03

1688.65%

S&P 500

15.76%

1.17

13.09%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-223.04%

EBIT to Interest (avg)

-9.35

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.10

Sales to Capital Employed (avg)

0.00

Tax Ratio

0.06%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

64.20%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.29

EV to EBIT

0.30

EV to EBITDA

0.33

EV to Capital Employed

5.53

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

1823.20%

ROE (Latest)

-372.78%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -18.28 MM

NET PROFIT(HY)

Higher at USD -8.61 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

OPERATING PROFIT(Q)

Highest at USD -3.76 MM

EPS(Q)

Highest at USD -0.43

-5What is not working for the Company

NET PROFIT(9M)

At USD -19.33 MM has Grown at -32.39%

ROCE(HY)

Lowest at -421.19%

Here's what is working for Calidi Biotherapeutics, Inc.

Operating Cash Flow

Highest at USD -18.28 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -8.61 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Profit

Highest at USD -3.76 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

EPS

Highest at USD -0.43

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Footer loading